News | October 11, 2012

Tranzbyte Acquires Marketing Rights to Low-Cost Open MRI Device

October 11, 2012 — Tranzbyte Corp. signed a preliminary agreement to acquire the North and South American marketing rights to one of the world's least expensive and most practical magnetic resonance imaging (MRI) machines, the Cirrus MRI from Hurricane Enterprises Ltd., a Hong Kong company.

Hurricane Enterprises obtained exclusive distribution rights to the Cirrus Open 0.2T MRI, developed in Canada under the funding of the National Research Council of Canada (NRC). The Cirrus MRI is an open MRI device intended to provide a physician with a patient's internal physiological imagery using MRI techniques, all without the use of ionizing radiation or advanced cryogenics.

The intellectual property rights for the machine continue to be held by the NRC, with manufacturing rights held by a consortium of scientists involved in the development of the technology. Worldwide distributor rights are held in a Hong Kong company controlled by Hurricane Enterprises Ltd.

Principle advantages of the Cirrus Open 0.2T MRI are its lower purchase price and lower operating costs. Because it does not require cooling with liquid helium, it is also much safer and more appropriate for use in remote areas. Also, the Cirrus MRI is more resilient against local power level fluctuations. The software-driven device comes equipped with Internet-ready capability, allowing radiologists and technicians anywhere with Internet access to review results in real time from the convenience of their urban hospital settings.

"I believe the Cirrus Open MRI will enable doctors and patients living in thousands of locales throughout the world to take advantage of this potentially life-saving technology at a cost per image far below what is considered standard," said David Gwyther, president of Tranzbyte.

For more information: www.tranzbyte.com

Related Content

ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
Videos | RSNA | April 03, 2019
ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displa
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Book Chapter Reports on Fonar Upright MRI for Hydrocephalus Imaging

Rotary misalignment of atlas (C1) and axis (C2). Image courtesy of Scott Rosa, DC, BCAO.

News | Magnetic Resonance Imaging (MRI) | March 20, 2019
Fonar Corp. reported publication of a chapter where the physician-author-researchers utilized the Fonar Upright Multi-...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...